Evermay Wealth Management LLC Purchases 266 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Evermay Wealth Management LLC grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 62.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 693 shares of the medical equipment provider’s stock after buying an additional 266 shares during the period. Evermay Wealth Management LLC’s holdings in Intuitive Surgical were worth $362,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Mirador Capital Partners LP boosted its holdings in Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after purchasing an additional 50 shares during the period. M.E. Allison & CO. Inc. bought a new position in Intuitive Surgical during the 4th quarter worth $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical in the 4th quarter valued at $82,517,000. Exome Asset Management LLC lifted its position in shares of Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after acquiring an additional 1,069 shares during the period. Finally, Consolidated Planning Corp grew its holdings in shares of Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after purchasing an additional 1,198 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Mizuho upped their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. CICC Research initiated coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Robert W. Baird boosted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Royal Bank of Canada raised their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Finally, Evercore ISI upped their price objective on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $571.88 on Friday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The business’s 50 day simple moving average is $550.40 and its 200 day simple moving average is $508.94. The stock has a market capitalization of $203.69 billion, a PE ratio of 89.22, a PEG ratio of 5.52 and a beta of 1.39.

Insider Activity

In related news, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the transaction, the insider now owns 8,757 shares in the company, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 28,843 shares of company stock valued at $15,357,560. 0.90% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.